Clinical Trial Update: Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy [NA]

View source ↗

Summary

A clinical trial is evaluating acupuncture and exercise to manage peripheral neuropathy caused by enfortumab vedotin plus pembrolizumab in patients with metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Padcev (enfortumab vedotin)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Bladder Cancer, Peripheral Neuropathy | NA | Status: NOT_YET_RECRUITING